The influence of sex and valve phenotype on fibrocalcific composition in severe aortic stenosis evolves with age
Related Experiment Video
Updated: Jun 6, 2026

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
Jun Shu1, Jingji Xu1, Didi Wen1
1Department of Radiology, Xijing Hospital, Fourth Military Medical University, Shaanxi Province, China.
Background:
While sex and valve phenotype influence fibrocalcific composition in older patients with aortic stenosis (AS), their roles in younger individuals remain unclear. We investigated the impact of sex, valve phenotype, and age on computed tomography (CT)-derived aortic valve composition in a relatively younger cohort with severe AS.
Methods:
This study included 221 patients with severe AS (mean age 64.0 ± 7.6 years; 102 women; 151 bicuspid aortic valve [BAV]) who underwent echocardiography and cardiac CT. CT quantified calcific density, fibrotic density, and fibrotic percentage. Group comparisons and Pearson correlations were performed.
Results:
Compared to men, women had lower calcific density (p < 0.001), higher fibrotic density (p = 0.001), and a higher fibrotic percentage (p < 0.001). These sex differences were more pronounced in patients aged < 65 years. Age correlated positively with calcific density (R = 0.225, p < 0.001) and negatively with fibrotic percentage (R = -0.280, p < 0.001) overall, driven primarily by women, whereas no significant correlations were observed in men. BAV-women exhibited higher fibrosis than BAV-men (p < 0.001), while TAV-women had lower calcification than TAV-men (p = 0.005). Valve phenotype (BAV vs. TAV) showed no significant association with tissue composition in the overall cohort or among patients < 65 years. However, among women aged ≥ 65 years, those with BAV had higher fibrotic and fibrocalcific densities than those with TAV.
Conclusions:
In our relatively younger severe AS cohort, sex is the primary determinant of fibrocalcific composition, particularly in patients under 65 years. In women aged ≥ 65 years, valve phenotype re-emerges as a significant factor.
Related Concept Videos
Mitral Stenosis I: Introduction
Aortic Regurgitation I: Introduction
Atherosclerosis I: Introduction
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation III: Medical Management

